CASE ALLEGATIONS: BioAge Labs is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. In the IPO, BioAge Labs sold 12.65 million shares at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback